Recovery
Rapid symptom relief and recovery1,3
Lowest catheter rate
Compared to leading BPH procedures2-7
Safe
Lowest rate of complications at one year*20
Durable
Low surgical retreatment rate2
Consistent, Durable Outcomes
Five-year data across UroLift™ System studies demonstrate that outcomes are rapid, durable and reproducible.1,2,10
Symptom Response Is Largely Consistent Among Controlled Subjects and Real-World Retrospective Cohorts
Sustained IPSS Improvement
Improvement in LUTS, as seen through average reduction in IPSS, has been largly consistent across various studies, showing rapid relief within two weeks and sustained effect through five years.1,2 Symptom relief is better than reported for medications.1,11
Quality of Life Improvement
Significant increase in quality of life scores with 51% improvement observed at 1 year and was sustained at 50% in a 5 year study, p<0.0001.2
Flow Rate Improvement
In addition to improving LUTS, the UroLift™ System treatment has demonstrated significant improvement in peak urinary flow rate (Qmax) of 3.5 mL/sec (44%) that was sustained to five years, p<0.0001.2
Low Retreatment Rate
The rate of surgical intervention for failure to cure with the UroLift™ System was low for a BPH procedure, with approximately 13.6% over the five year study.1,2
Extensive Clinical Evidence Support the UroLift™ System
For 10+ years, supported by over 145 peer-reviewed and 22 sponsored publications, the UroLift™ System has been proven to provide generally consistent outcomes between randomized clinical trials and the real world, in a large variety of prostate types, including those with obstructive median lobe and large prostates up to 100cc.18,19
Learn about more about the UroLift™ System procedure and devices.
Learn about our onboarding process and path to long-term success.
Explore AUA’s clinical spotlight on advancements in minimally invasive surgical options for the management of BPH.
*Procedural complications were defined as complications requiring a return procedure in the outpatient setting ≥1d post-procedure.
References
1.
Roehrborn, J Urology 2013
2.
Roehrborn, Can J Urol 2017
3.
Shore, Can J Urol 2014
4.
Bachmann, Eur Urol 2013
5.
McVary, J Urol 2016
6.
Mollengarden, Prostate Cancer Prostatic Dis 2018
7.
Das, Can J Urol 2019
8.
AUA BPH Guidelines 2003, 2020
9.
McVary, Urology 2019
10.
Eure, J Endourol 2019
11.
AUA BPH Guidelines 2003
12.
McVary, J Urol 2021
13.
McVary, J Urol 2015
14.
Gilling, Can J Urol 2022
15.
Gilling, J Urol 2018
16.
Bachmann, Eur Urol 2016
17.
FDA BPH Guidance
18.
Eure, J Endourol 2019
19.
Rukstalis, Prostate Cancer Prostatic Dis 2018
20.
Kaplan, Prostate Cancer Prostatic Dis 2023
Healthcare Professional Confirmation
The information on the page you are about to enter is intended for Healthcare Professionals
only.
By clicking the box below, you confirm that you are a Healthcare Professional.